We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.26B
AUM Growth
-$20.1M
Cap. Flow
-$50.3M
Cap. Flow %
-1.18%
Top 10 Hldgs %
30.91%
Holding
425
New
29
Increased
142
Reduced
157
Closed
18

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$26.3M
2
NDSN icon
Nordson
NDSN
+$6.48M
3
AVGO icon
Broadcom
AVGO
+$6.19M
4
COP icon
ConocoPhillips
COP
+$5.55M
5
ISRG icon
Intuitive Surgical
ISRG
+$3.83M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19.3M
2
DE icon
Deere & Co
DE
+$5.46M
3
MSFT icon
Microsoft
MSFT
+$5.11M
4
MRCY icon
Mercury Systems
MRCY
+$4.37M
5
BABA icon
Alibaba
BABA
+$3.21M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 17.37%
3 Financials 11.62%
4 Industrials 9.59%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBCT
276
DELISTED
People's United Financial Inc
PBCT
$653K 0.02%
37,381
+678
+2% +$11K
VNT icon
277
Vontier
VNT
$4.63B
$645K 0.02%
19,183
-3,258
-15% -$111K
MCHP icon
278
Microchip Technology
MCHP
$44.2B
$638K 0.02%
8,310
+2,006
+32% +$150K
TPL icon
279
Texas Pacific Land
TPL
$24.2B
$624K 0.01%
4,644
+963
+26% +$150K
ROP icon
280
Roper Technologies
ROP
$39.9B
$623K 0.01%
1,396
+1
+0.1% +$479
PPG icon
281
PPG Industries
PPG
$25.7B
$615K 0.01%
4,303
VRSK icon
282
Verisk Analytics
VRSK
$23.6B
$611K 0.01%
3,051
+1
+0% +$194
CFR icon
283
Cullen/Frost Bankers
CFR
$10.3B
$602K 0.01%
5,075
DOV icon
284
Dover
DOV
$28.3B
$600K 0.01%
3,860
+544
+16% +$90.1K
SNPS icon
285
Synopsys
SNPS
$78.8B
$599K 0.01%
2,000
DKS icon
286
Dick's Sporting Goods
DKS
$19.2B
$598K 0.01%
+4,995
New +$581K
APTV icon
287
Aptiv
APTV
$10.3B
$586K 0.01%
3,934
+1
+0% +$156
LXP icon
288
LXP Industrial Trust
LXP
$3.58B
$574K 0.01%
9,003
TRI icon
289
Thomson Reuters
TRI
$45.2B
$572K 0.01%
4,915
EA
290
DELISTED
Electronic Arts
EA
$571K 0.01%
4,011
+1
+0% +$140
CHTR icon
291
Charter Communications
CHTR
$18.3B
$570K 0.01%
784
+3
+0.4% +$2.28K
XYL icon
292
Xylem
XYL
$28.3B
$568K 0.01%
4,594
SO icon
293
Southern Company
SO
$105B
$561K 0.01%
9,059
-1,580
-15% -$102K
LNC icon
294
Lincoln National
LNC
$8.75B
$550K 0.01%
8,001
+1
+0% +$65
GLW icon
295
Corning
GLW
$136B
$533K 0.01%
14,617
PWR icon
296
Quanta Services
PWR
$99.4B
$532K 0.01%
+4,676
New +$469K
WST icon
297
West Pharmaceutical
WST
$24.8B
$531K 0.01%
1,250
-25
-2% -$10.5K
ORLY icon
298
O'Reilly Automotive
ORLY
$75.3B
$521K 0.01%
12,780
+300
+2% +$12K
ELV icon
299
Elevance Health
ELV
$86.2B
$513K 0.01%
1,376
+163
+13% +$61.9K
LECO icon
300
Lincoln Electric
LECO
$15.1B
$510K 0.01%
3,960

Similar funds

Bradley Foster & Sargent's Q3 2021 Portfolio in Review

As of Q3 2021, Bradley Foster & Sargent held 425 positions worth $4.26B, down 0.47% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent's Q3 2021 filing shows 29 new, 142 increased, 157 reduced and 18 closed positions. Its largest new stake was Broadcom: 127,340 shares worth $6.17M. The largest sale was Vertex Pharmaceuticals, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q3 2021 buy was Broadcom: 127,340 shares worth $6.17M.
  • Bradley Foster & Sargent added most to Oracle in Q3 2021, an estimated $26.3M increase.
  • Bradley Foster & Sargent's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $19.3M.
  • Bradley Foster & Sargent fully exited Mercury Systems in Q3 2021, selling an estimated $4.37M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $4.26B portfolio in Q3 2021.
  • Bradley Foster & Sargent opened 29 new positions and closed 18 in Q3 2021.
  • Bradley Foster & Sargent's portfolio value fell 0.47% quarter-over-quarter to $4.26B.

Based on Bradley Foster & Sargent's 13F filing for Q3 2021, filed 10 Nov 2021.